Related Experiment Videos
Pulmonary function in dogs with mitral valve regurgitation.
American Journal of Veterinary Research
|December 1, 1986
Summary
Congestive heart failure from mitral valve regurgitation significantly impairs pulmonary function in dogs. Dogs with higher left atrial pressures experienced severe respiratory changes, while those with lower pressures showed minimal impact.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Veterinary Science
Background:
- Mitral valve regurgitation (MVR) can lead to congestive heart failure.
- The impact of MVR on pulmonary function requires further elucidation, particularly in the context of varying severity.
Purpose of the Study:
- To investigate the effects of induced mitral valve regurgitation on hemodynamic and pulmonary function in dogs.
- To compare the physiological responses between dogs with and without clinical signs of congestive left ventricular failure.
Main Methods:
- Mitral valve regurgitation was surgically induced in two groups of dogs.
- Dogs were categorized based on the presence (Group 2) or absence (Group 1) of congestive left ventricular failure signs.
- Hemodynamic parameters (pressures, diameters) and pulmonary function metrics (gas exchange, compliance, resistance) were assessed.
Main Results:
- Group 2 dogs (mean left atrial pressure > 30 mm Hg) exhibited increased heart rate, pulmonary arterial pressure, and chamber diameters.
- These dogs also showed decreased arterial oxygen tension, lung compliance, and lung volumes, with increased pulmonary resistance.
- Group 1 dogs (mean left atrial pressure < 30 mm Hg) had moderate hemodynamic changes but preserved pulmonary function at rest, with decreased arterial oxygen tension only during exercise.
Conclusions:
- Severe mitral valve regurgitation leading to congestive heart failure significantly compromises pulmonary function in dogs.
- The degree of left atrial pressure elevation correlates with the severity of pulmonary dysfunction in MVR.
- Pulmonary function monitoring is crucial in dogs with mitral valve regurgitation, especially in advanced stages.